Ranibizumab for macular edema after branch retinal vein occlusion: One initial injection versus three monthly injections

Retina

Volumn 37, Issue 4, 2017, Pages 702-709

  Miwa, Yuko ^a   Muraoka, Yuki ^a   Osaka, Rie ^b   Ooto, Sotaro ^a   Murakami, Tomoaki ^a   Suzuma, Kiyoshi ^a   Takahashi, Ayako ^a   Iida, Yuto ^a   Yoshimura, Nagahisa ^a   Tsujikawa, Akitaka ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Branch retinal vein occlusion; Intravitreal ranibizumab injection; Macular edema

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR;

AGE DISTRIBUTION; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL FOVEAL THICKNESS; DRUG EFFICACY; FEMALE; HUMAN; INTERVENTION STUDY; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; TREATMENT DURATION; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; COMPLICATION; DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA FOVEA; RETINAL VEIN OCCLUSION;

AGED; ANGIOGENESIS INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOVEA CENTRALIS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MIDDLE AGED; PROSPECTIVE STUDIES; RANIBIZUMAB; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 85017353979     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000001224     Document Type: Article

References (18)

1. Hayreh SS, Podhajsky PA, Zimmerman MB. Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 2009;116:1188-1194.
2. Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 2014;41:1-25.
3. Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-1101.
4. Wong TY, Scott IU. Clinical practice. Retinal-vein occlusion. N Engl J Med 2010;363:2135-2144.
5. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: sixmonth primary end point results of a phase III study. Ophthalmology 2010;117:1102-1112.
6. Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011;118:2041-2049.
7. Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology 2012;119:802-809.
8. Varma R, Bressler NM, Suñer I, et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012;119:2108-2118.
9. Campochiaro PA, Sophie R, Pearlman J, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 2014;121:209-219.
10. Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology 2015;122:538-544.
11. Clark WL, Boyer DS, Heier JS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52- Week results of the VIBRANT study. Ophthalmology 2016;123:330-336.
12. Rayess N, Rahimy E, Shah CP, et al. Incidence and clinical features of post-injection endophthalmitis according to diagnosis. Br J Ophthalmol 2015;0:1-4.
13. Kida T, Tsujikawa A, Muraoka Y, et al. Cotton Wool Spots after anti-vascular endothelial growth factor therapy for macular edema associated with central retinal vein occlusion. Ophthalmologica 2016;235:106-113.
14. Fan C, Wang Y, Ji Q, et al. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion. Curr Eye Res 2014;39:938-943.
15. Campochiaro PA, Wykoff CC, Singer M, et al. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study. Ophthalmology 2014;121:2432-2442.
16. Ito Y, Saishin Y, Sawada O, et al. Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. Clin Ophthalmol 2015;9:175-180.
17. Narayanan R, Panchal B, Das T, et al. A randomised, doublemasked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1. Br J Ophthalmol 2015;99:954-959.
18. Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG. Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology 2013;120:1057-1063.